A cohort study on protocol-based nurse-led out-patient management of post-chemotherapy low-risk febrile neutropenia

被引:7
作者
Ying, Fiona Lim Mei [1 ]
Ping, Maria Choy Yin [1 ]
Tong, Macy [2 ]
Yan, Elaine Yim Pik [1 ]
Yee, Tracy Lui Siu [1 ]
Ting, Lam Yuk [1 ]
Sim, Anita Lo Wing [2 ]
Yu, Lui Cheuk [1 ]
Shiu, Bosco Lam Hoi [3 ]
Kin, Ashley Cheng Chi [1 ]
机构
[1] Princess Margaret Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China
[2] Prince Wales Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[3] Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
Low risk; Febrile neutropenia; Out-patient; Solid cancers; EARLY HOSPITAL DISCHARGE; CANCER-PATIENTS; MULTINATIONAL-ASSOCIATION; SUPPORTIVE-CARE; ORAL ANTIBIOTICS; THERAPY; INDEX; FEVER;
D O I
10.1007/s00520-018-4157-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose International guidelines adopt risk stratification approach to manage patients with low-risk febrile neutropenia patients. We developed this out-patient program using shared-care model with professional input and patient empowerment, so as to reduce patients' psychological burden from hospitalization and to improve the cost-effectiveness of management. Methods This is a prospective cohort study to compare the efficacy and safeness of the out-patient program when compared with traditional in-patient care. Patients with solid tumors, developed febrile neutropenia with Multinational Association of Supportive Care in Cancer score of at least 21, and good performance status were included. After initial assessment and the first dose of oral antibiotics, patients were observed in the ambulatory center. Stable patients were discharged home after 4 h of observation and nurse counseling. Patients' condition and clinical progress were regularly reviewed by specialist nurses within the following week by telephone and nurse clinic follow-up. The primary objective of the study is success rate, which defined as the resolution of fever and infection, without hospitalization or any change in antibiotics. Results From September 2014 to December 2016, a total of 38 patients were enrolled. Majority were female with breast cancer (97%). Two patients required hospitalization due to persistent fever. The success rate of the out-patient program was not significantly different from the historical in-patient cohort (94.9 versus 97.4%, p = 0.053). No mortality was observed. Patients' compliance to the program was 100%, to telephone follow-up, nurse clinic visits, and daily temperature record. Conclusion Out-patient management of patients with low-risk febrile neutropenia is effective and safe through implementation of a structured protocol with joint inputs and engagement from clinicians, oncology nurses, and patients.
引用
收藏
页码:3039 / 3045
页数:7
相关论文
共 25 条
  • [1] QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA
    BODEY, GP
    BUCKLEY, M
    SATHE, YS
    FREIREICH, EJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) : 328 - +
  • [2] Carstensen Mads, 2008, J Support Oncol, V6, P199
  • [3] Cherif H, 2006, HAEMATOL-HEMATOL J, V91, P215
  • [4] USE OF ANTIBIOTICS IN CANCER AND LEUKEMIA
    CURTIN, JA
    MARSHALL, BD
    [J]. JOURNAL OF CHRONIC DISEASES, 1962, 15 (JUL): : 713 - &
  • [5] Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia
    Elting, Linda S.
    Lu, Charles
    Escalante, Carmelita P.
    Giordano, Sharon H.
    Trent, Jonathan C.
    Cooksley, Catherine
    Avritscher, Elenir B. C.
    Shih, Ya-Chen Tina
    Ensor, Joe
    Bekele, B. Nebiyou
    Gralla, Richard J.
    Talcott, James A.
    Rolston, Kenneth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 606 - 611
  • [6] Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
    Flowers, Christopher R.
    Seidenfeld, Jerome
    Bow, Eric J.
    Karten, Clare
    Gleason, Charise
    Hawley, Douglas K.
    Kuderer, Nicole M.
    Langston, Amelia A.
    Marr, Kieren A.
    Rolston, Kenneth V. I.
    Ramsey, Scott D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : 794 - 810
  • [7] Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
    Freifeld, Alison G.
    Bow, Eric J.
    Sepkowitz, Kent A.
    Boeckh, Michael J.
    Ito, James I.
    Mullen, Craig A.
    Raad, Issam I.
    Rolston, Kenneth V.
    Young, Jo-Anne H.
    Wingard, John R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (04) : E56 - E93
  • [8] Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department
    Gaieski, David F.
    Mikkelsen, Mark E.
    Band, Roger A.
    Pines, Jesse M.
    Massone, Richard
    Furia, Frances F.
    Shofer, Frances S.
    Goyal, Munish
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (04) : 1045 - 1053
  • [9] Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia
    Girmenia, Corrado
    Russo, Eleonora
    Carmosino, Ida
    Breccia, Massimo
    Dragoni, Francesco
    Latagliata, Roberto
    Mecarocci, Sergio
    Morano, Salvatore Giacomo
    Stefanizzi, Caterina
    Alimena, Giuliana
    [J]. ANNALS OF HEMATOLOGY, 2007, 86 (04) : 263 - 270
  • [10] Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network
    Hui, Edwin Pun
    Leung, Linda K. S.
    Poon, Terence C. W.
    Mo, Frankie
    Chan, Vicky T. C.
    Ma, Ada T. W.
    Poon, Annette
    Hui, Eugenie K.
    Mak, So-shan
    Lai, Maria
    Lei, Kenny I. K.
    Ma, Brigette B. Y.
    Mok, Tony S. K.
    Yeo, Winnie
    Zee, Benny C. Y.
    Chan, Anthony T. C.
    [J]. SUPPORTIVE CARE IN CANCER, 2011, 19 (10) : 1625 - 1635